Skip to main content
Veterinary Medicines

Tetanusan 50% N (44 g + 12,5 g + 2 g)/100 ml Roztwór do wstrzykiwań

Authorised
  • Calcium gluconate
  • Magnesium chloride hexahydrate
  • Sodium glycerophosphate pentahydrate

Product identification

Medicine name:
Tetanusan 50% N (44 g + 12,5 g + 2 g)/100 ml Roztwór do wstrzykiwań
Active substance:
  • Calcium gluconate
  • Magnesium chloride hexahydrate
  • Sodium glycerophosphate pentahydrate
Target species:
  • Cattle
  • Pig
  • Horse
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Calcium gluconate
    44.00
    gram(s)
    /
    1.00
    gram(s)
  • Magnesium chloride hexahydrate
    12.50
    gram(s)
    /
    1.00
    gram(s)
  • Sodium glycerophosphate pentahydrate
    2.00
    gram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Kon-Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1812
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."